Onconetix Announces 1-for-10 Reverse Stock Split Effective November 6
Onconetix (ONCO) has officially approved a 1-for-10 reverse stock split, which is scheduled to take effect on November 6. This corporate action will reduce the company's outstanding common shares from approximately 5.89 million to roughly 588,677, based on share counts reported as of October 21. The restructuring will not alter the company's authorized common share count of 250 million or its par value per share. Shareholders who would otherwise receive fractional shares due to the split will be compensated with cash payments instead.
Topics: reverse stock split shareholder equity stock restructuring
Read the full article at Seeking Alpha
Part of the story ReTo Eco-Solutions Announces Eight-to-One Reverse Stock Split (7 articles)